MAP2K7 and glioblastoma: Ethyl pyruvate [52], trametinib [53], amentoflavone [54], hyperforin [55], berberine [56], imipramine [57], and protein neddylation inhibitor MLN4924 [58] inhibit glioblastoma cells migration and invasion via suppressing MEK-ERK pathway.